Pfizer (PFIZER.NS) Hisse Fiyat
Pfizer Fiyat
Gelir, son 19 yılda yıllık bileşik %7,0 artarak 25,20 Md INR seviyesine ulaştı. Hisse başına kâr, son 19 yılda yıllık %10,6 büyüdü. Pfizer şirketinde net marj %28,7 seviyesinde bulunuyor; birkaç yıl önceki %23,5 seviyesine göre yükseldi. Pfizer şu anda yaklaşık %3,41 temettü verimi sunuyor. Temettü dağıtım oranı, kârın yaklaşık %37 düzeyindedir. Temettü, son 19 yılda yıllık %9,7 artış gösterdi. Analistler 6.222,00 INR medyan fiyat hedefi belirliyor; bu, güncel fiyatın %63,1 üzerinde bir seviyeye işaret ediyor. 8 analistten 5 tanesi hisse için alım öneriyor — genel konsensüs: Al.
Pfizer hisse senedi fiyatı
Bu verilere Eulerpool API üzerinden ulaşın
Ayda 100.000 ücretsiz istek · kredi kartı yok
Pfizer iş modeli ve hisse analizi
Pfizer hakkında sık sorulan sorular
The business model of Pfizer Ltd revolves around pharmaceutical research, development, manufacturing, and sales. As a leading global biopharmaceutical company, Pfizer focuses on discovering breakthrough medicines and vaccines for various health conditions. With a diverse portfolio, Pfizer aims to improve patient lives and promote better health outcomes by investing in innovative research and development. Through strategic partnerships and collaborations, Pfizer strives to advance healthcare solutions while maintaining a strong commitment to delivering quality products. By upholding high standards of scientific integrity and ethical business practices, Pfizer continues to contribute to the well-being of individuals worldwide.
Pfizer Ltd is primarily active in the pharmaceutical industry. Its core business focuses on the research, development, manufacture, and sale of a wide range of pharmaceutical products. Pfizer Ltd is a renowned global pharmaceutical company, known for its breakthrough medicines and innovative therapies across various therapeutic areas. With a strong presence in the healthcare sector, Pfizer Ltd strives to enhance and improve the well-being of individuals worldwide.
The main competitors of Pfizer Ltd in the market include pharmaceutical companies such as Johnson & Johnson, Merck & Co., GlaxoSmithKline, and Novartis.
Pfizer Ltd. is a renowned pharmaceutical company with a rich history and background. Founded in 1849, Pfizer has evolved into a leading global player in the healthcare industry. With headquarters in the United States, the company has expanded its reach worldwide, including operations in India through Pfizer Ltd. Pfizer Ltd. is committed to discovering, developing, and manufacturing innovative medicines, vaccines, and consumer healthcare products. The company's relentless pursuit of medical advancements and dedication to improving people's lives has earned Pfizer Ltd. a strong reputation and recognition as a trusted name in the pharmaceutical sector.
Pfizer Ltd, a renowned pharmaceutical company, has achieved several significant milestones over the years. Notably, Pfizer is credited with the development of life-saving drugs like Viagra, Lipitor, and Zoloft, which have had a tremendous impact on global healthcare. Pfizer's contributions in the fields of immunology, oncology, and cardiology have not gone unnoticed, establishing the company as a leader in medical advancements. Pfizer's commitment to research and innovation has resulted in groundbreaking treatments, ensuring better clinical outcomes for patients worldwide. This dedication to excellence and their bold pursuit of scientific breakthroughs have made Pfizer Ltd a trusted and influential player in the pharmaceutical industry.
Pfizer Ltd, a leading pharmaceutical company, has a prominent presence in various countries and regions globally. The company operates in several key markets, including the United States, Europe, Asia-Pacific, Latin America, and Africa. With its headquarters in New York, Pfizer Ltd has established a strong foothold in the United States, utilizing its extensive network for research, development, and distribution of innovative healthcare solutions. Additionally, Pfizer Ltd's operations span across Europe, where it operates in numerous countries, catering to diverse healthcare needs. Further, the company's presence extends to the Asia-Pacific region, Latin America, and Africa, emphasizing its commitment to addressing global health challenges effectively.
Pfizer Ltd represents a set of core values and a strong corporate philosophy. As a renowned pharmaceutical company, Pfizer Ltd is committed to innovation and scientific advancement in the healthcare industry. The company believes in providing high-quality and safe medications to improve patient outcomes. Pfizer Ltd also emphasizes integrity, ethical practices, and transparency in all aspects of its operations. With a dedication to research and development, Pfizer Ltd aims to discover and deliver life-saving and life-enhancing therapies for people worldwide. This commitment, along with a customer-centric approach, makes Pfizer Ltd a trusted name in the pharmaceutical sector.
Analistler şu anda Pfizer hissesi için ortalama 6.389,08 INR hedef fiyat belirliyor (medyan: 6.222,00 INR); bu, son fiyata göre +67,5 % anlamına gelir. Konsensüs 8 analist notuna dayanır.
9 analist şu anda Pfizer hissesini değerlendiriyor: 6 al, 3 tut, 0 sat öneriyor.
Güncel döviz kuruyla Pfizer hissesi 35,73 EUR (3.814,00 INR) seviyesindedir.
Pfizer hissesi (PFIZER.NS) 2 borsada işlem görür, bunlar arasında: NSE (Indien) (PFIZER.NS).
Pfizer Ltd is a pharmaceutical company that focuses on the research, development, and marketing of products for the prevention and treatment of diseases. It has a global customer base and operates in various medical fields such as oncology, immunology, neurology, and infectious diseases. The company offers a wide range of medications, from well-established drugs to new therapies and biotechnological products. Its business model is centered on growth and profitability, with investments in research and development to remain competitive. Pfizer Ltd is organized into different divisions, including oncology, infectious diseases, immunology, and neurology, and also engages in the development of biotechnology products. Its products are marketed globally through pharmaceutical distribution channels. Overall, Pfizer Ltd strives to improve the health of patients worldwide through the development and marketing of innovative therapies.
'nin Pfizer hasılatı 25,20 Md INR'dir. Bu rakam, mevcut finansal verilere dayanmakta ve şirketin iş performansını yansıtmaktadır.
'nin Pfizer karı 7,22 Md INR'dir. Net kar, tüm giderleri düştükten sonra şirketin kârlılığını gösterir.
Pfizer'nin Fiyat/Kazanç (F/K) oranı şu anda 24,15'dir. F/K oranı, cari hisse fiyatını hisse başına kazançla karşılaştırır ve yatırımcıların Pfizer hisse senedinin değerlemesini değerlendirmelerine yardımcı olur.
Pfizer'nin Fiyat/Satış (F/S) oranı şu anda 6,93'dir. F/S oranı, pazar kapitalizasyonunu yıllık gelirle karşılaştırır ve Pfizer hisse senedinin değerleme metriği olarak hizmet eder.
Pfizer'nin Eulerpool Kalite Puanı 3/10'dur.
Pfizer'nin ISIN'i INE182A01018'dir. ISIN (Uluslararası Menkul Kıymetler Kimlik Numarası), menkul kıymetler için küresel olarak benzersiz bir tanımlayıcıdır.
Pfizer'nin ticker'ı PFIZER.NS'dir. Ticker sembolü, Pfizer hisseleri borsada işlem görmek için kullanılır.
Pfizer Hissesi
Pfizer Emsaller Grubu
Pfizer Ticker
Pfizer FIGI
Pfizer'nin tüm temel göstergeleri ve derinlemesine analizi
Pfizer hissesine yönelik aktienanalizimiz, satış, kar, P/E oranı, P/S oranı, EBIT gibi önemli mali kriterleri içermekte olup, dividende bilgilerini de ele almaktadır. Ayrıca, hisseler, piyasa değeri, borçlar, özsermaye ve Pfizer şirketin yükümlülükleri gibi konuları incelemekteyiz. Bu konular hakkında daha detaylı bilgilere ihtiyacınız varsa, web sitemizin alt sayfalarında kapsamlı analizler sunuyoruz: